1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
Biotech stocks typically are considered one of Wall Street’s more aggressive sources of growth. These companies spend years and gobs of money to create breakthrough biological treatments and diagnostic...
Despite political posturing over high drug prices, the sector’s prospects remain bright, thanks to a steady stream of new products.
Seth Klarman was prescient in recognizing that the genomics revolution would supercharge the biotech industry.
More Investing News »